课题基金基金详情
SP-D C92T基因变异调控sema 3A 介导的脓毒症肾小管节段间“交互作用”机制研究
结题报告
批准号:
81971869
项目类别:
面上项目
资助金额:
55.0 万元
负责人:
刘娇
依托单位:
学科分类:
器官功能衰竭与支持
结题年份:
2023
批准年份:
2019
项目状态:
已结题
项目参与者:
刘娇
国基评审专家1V1指导 中标率高出同行96.8%
结合最新热点,提供专业选题建议
深度指导申报书撰写,确保创新可行
指导项目中标800+,快速提高中标率
客服二维码
微信扫码咨询
中文摘要
脓毒症急性肾损伤(AKI)发病机制与肾小管节段交互作用有关,即S1节段传感LPS效应诱发S2节段氧化应激损伤。我们既往研究证实SP-D 92C为脓毒症AKI易感基因,但机制不明。深入研究发现外源性SP-D调节S1节段分泌sema 3A,据此提出假说:SP-D 92C致脓毒症AKI易感机制,与92C型SP-D蛋白胶原尾部活化S1节段mTOR依赖sema 3A分泌通路,加剧肾小管节段交互作用有关。本项目应用人SP-D 92C和92T敲入小鼠构建脓毒症模型,活体双光子成像比较肾脏氧化应激及肾小管节段交互作用差异; 培养SP-D KO小鼠S1和S2节段,荧光染色观察92C或92T型SP-D蛋白不同结构域与S1节段TLR4或SIRP-a受体结合,分析活化下游mTOR或SHP1通路对sema 3A分泌影响,明确其结合S2节段sema 3A受体后促氧化应激作用,揭示基因变异在脓毒症AKI中的分子机制。
英文摘要
The mechanisms of sepsis-induced acute kidney injury(AKI) is related with renal tubular segments “crosstalk”, that is S1 Segment of renal tubular sensing Endotoxin which may induce oxidative stress injury of S2 Segment. It has been observed by our clinical study that sepsis patients with SP-D 92C allele(rs721917) were susceptible to AKI,however the related mechanisms is still unknown. Our previous results showed sema 3A secretion from S1 segment could be modulated by exogenous SP-D. Based on this we hypothesize “the mechanisms of sepsis patients with SP-D 92C allele is more susceptible to AKI is related with mTOR-dependent sema 3A secretion pathway enhancing tubular S1 and S2 segments crosstalk activated by collagen tail of 92C type SP-D protein”, the humanized knock-in mice with different alleles(92C or 92T) will be used to set up sepsis model, the renal oxidative stress reaction and in vivo renal tubular S1 and S2 segments “cross talk” will be compared. The S1 segments of renal tubular from SP-D knockout mice will be separated and cultured to detect whether the different domains of SP-D 92C or SP-D 92T protein combined TLR4 or SIRP-a receptor on S1 segment renal tubular epithelial cells, the effects of activated mTOR or SHP1 pathway on sema 3A secretion will be analyzed, the influence of sema 3A binding on its receptor to tubular S2 segment oxidative stress will also be detected.The project aims to explore the molecule mechanisms of gene variation in sepsis-induced AKI.
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
Effect of Nebulized Amphotericin B in Critically ill Patients With Respiratory Candida spp. De-colonization: A Retrospective Analysis.
雾化两性霉素 B 对呼吸道念珠菌危重患者的影响非殖民化:回顾性分析。
DOI:10.3389/fmed.2021.723904
发表时间:2021
期刊:Frontiers in medicine
影响因子:3.9
作者:Du H;Wei L;Li W;Huang B;Liu Y;Ye X;Zhang S;Wang T;Chen Y;Chen D;Liu J
通讯作者:Liu J
DOI:10.3389/fmed.2021.584813
发表时间:2021
期刊:Frontiers in medicine
影响因子:3.9
作者:Liu J;Zhang S;Huang S;Chen Y;Zhang L;Du H;Wang T;Liu Y;Xu Y;Chen D
通讯作者:Chen D
Efficacy of Thymosin Alpha 1 in the Treatment of COVID-19: A Multicenter Cohort Study.
胸腺肽 Alpha 1 治疗 COVID-19 的功效:一项多中心队列研究
DOI:10.3389/fimmu.2021.673693
发表时间:2021
期刊:Frontiers in immunology
影响因子:7.3
作者:Liu J;Shen Y;Wen Z;Xu Q;Wu Z;Feng H;Li Z;Dong X;Huang S;Guo J;Zhang L;Chen Y;Li W;Zhu W;Du H;Liu Y;Wang T;Chen L;Teboul JL;Annane D;Chen D
通讯作者:Chen D
DOI:10.1186/s13613-019-0617-5
发表时间:2020-01
期刊:Annals of Intensive Care
影响因子:8.1
作者:Jiao Liu;Jianyin Yao;Lidi Zhang;Yizhu Chen;Hangxiang Du;Zhenliang Wen;Dechang Chen
通讯作者:Jiao Liu;Jianyin Yao;Lidi Zhang;Yizhu Chen;Hangxiang Du;Zhenliang Wen;Dechang Chen
DOI:10.1097/cm9.0000000000002543
发表时间:2022-11-05
期刊:Chinese medical journal
影响因子:6.1
作者:
通讯作者:
IL-33通过mTORC1调控ILC2糖代谢保护脓毒症急性肾损伤的分子机制研究
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    55万元
  • 批准年份:
    2021
  • 负责人:
    刘娇
  • 依托单位:
国内基金
海外基金